ClinicalTrials.Veeva

Menu

Change of Nerve Conduction Properties in IVIg Dependent Neuropathies

U

University of Cologne

Status

Unknown

Conditions

Guillain-Barre Syndrome
Multifocal Motor Neuropathy
CIDP

Study type

Observational

Funder types

Other

Identifiers

NCT01655394
01607831337

Details and patient eligibility

About

IVIg exert a variety of different immunomodulatory effects and several mechanism of action have been proposed for IVIg. In this study the role of IVIg on short term nerve conduction in patients with immune-mediated neuropathies will be explored.

Full description

IVIg exert a variety of different immunomodulatory effects and several mechanism of action have been proposed for IVIg. In this study the role of IVIg on short term nerve conduction in patients with immune-mediated neuropathies will be explored

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • immune neuropathy
  • age above 18 y
  • IVIg treatment

exclusion:

  • no IVIg treatment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems